(Q33828587)

29 July 2017

1 reference

title

The pathologist's role in sentinel lymph node evaluation (English)

1 reference

29 July 2017

Cochran AJ

1

1 reference

29 July 2017

1 January 2000

1 reference

Seminars in Nuclear Medicine

29 July 2017

1 reference

29 July 2017

30

1 reference

29 July 2017

1

1 reference

29 July 2017

11-17

1 reference

Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Prognostic significance of lymph node dissection in the treatment of malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

The role of elective lymph node dissection in melanoma: rationale, results, and controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

"Prophylactic" lymph node dissection in melanoma: does it help?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

A soluble protein characteristic of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

S100 protein is present in cultured human malignant melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

S100 protein: a marker for human malignant melanomas?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Detection of S-100 protein as an aid to the identification of melanocytic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

S‐100Protein: A Marker for Melanocytic Tumors a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Occult melanoma in lymph nodes detected by antiserum to S-100 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Lymphatic drainage of skin to a sentinel lymph node in a feline model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Technical details of intraoperative lymphatic mapping for early stage melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Optimal selective sentinel lymph node dissection in primary malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Intraoperative identification of sentinel lymph node in patients with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Lymphatic mapping and sentinel node biopsy for early stage melanoma: how we do it at the M. D. Anderson Cancer Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Intraoperative lymphatic mapping for early-stage melanoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Sentinel lymph node uptake of two different technetium-labeled radiocolloids,

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Nodal nevi and cutaneous melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

inferred from DOI database lookup

7 January 2021

based on heuristic

More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2800%2980057-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-2998(00)80057-4

1 reference

29 July 2017

1 reference

PubMed ID

10656239